Evaluation of Minimal Residual Disease in Acute Lymphoblastic Leukemia
- MeSH Terms
Leukemia; Lymphoid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Flow Cytometry; Polymerase chain reaction; Hematopoietic Stem Cell Transplantation; Genetic Testing; Bone Marrow; Bone Marrow Cells; Bone Marrow Examination; Blood Cells; Blood Cell Count; Cell Count; Hemodilution; Gene Rearrangement, B-Lymphocyte; neoplasm, residual
- Guideline Contact
- Julie Donovan ([email protected])
- Keywords
- MRD ALL; acute lymphoblastic leukemia; minimal/measurable residual disease, B-ALL; T-ALL; pediatric; adult; cap; college of american pathologists
- Expected Publication Date
- Q2, 2026
- Countries of Application
- United States
- Guideline Publication Status
- Development
- Languages
- English
- Authors
- CAP (US)
- Publication Year
- unpublished